Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$35.24 USD
-0.32 (-0.90%)
Updated Apr 26, 2024 04:00 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TNDM 35.24 -0.32(-0.90%)
Will TNDM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNDM
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
Tandem Diabetes (TNDM) Gains From Innovation Amid Macro Issues
TNDM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?
Tandem Diabetes (TNDM) Gains From Innovation Amid Competition
Why Is Tandem Diabetes Care (TNDM) Up 27.4% Since Last Earnings Report?
Other News for TNDM
Wells upgrades Tandem Diabetes on positive endocrinologist survey
Wells Fargo gets more bullish on Tandem Diabetes, upgrades shares
Leerink upgrades Tandem Diabetes to Outperform on attractive risk/reward setup
Leerink gets more bullish on Tandem Diabetes, upgrades shares
What's Driving Tandem Diabetes Care Inc's Surprising 31% Stock Rally?